The time is now: D CEO and D CEO Healthcare have opened nominations for their fourth annual Excellence in Healthcare awards feature. Full Story
UT Southwestern Medical Center biochemist Dr. Benjamin Tu was named a finalist in the 2017 Blavatnik National Awards for Young Scientists. Full Story
BioNorthTX, the advocacy and trade association for the region’s biotech companies, has a new president and has added board members. Full Story
AT&T has announced that it will open a so-called innovation center at the Texas Medical Center in Houston to help entrepreneurs develop digital health platforms that can better connect patients wirelessly. Full Story
D CEO magazine and D Healthcare Daily are pleased to recognize outstanding healthcare CEOs, practitioners, and other innovative industry leaders with the new Excellence in Healthcare Awards program. Full Story
Dr. Thomas C. Südhof, adjunct professor of neuroscience and former chairman of the department at UT Southwestern Medical Center, was named a 2013 Nobel Prize winner for medicine Monday, for his and others’ research into how cellular transport systems work. Südhof earned the prize alongside James Rothman and Randy Schekman. “I’m absolutely surprised,” said Südhof. “Every scientist dreams of this. I didn’t realize there was chance I would be awarded the prize. I am stunned and really happy to share the prize with James Rothman and Randy Schekman.” Südhof, now at Stanford University’s medical school, was recognized for work performed at UT Southwestern on… Full Story
Acute- and long-term-care hospitals will see small increases in Medicare payments beginning in 2014, under a proposed payment schedule released Friday by the Centers for Medicare and Medicaid Services Services.
Dallas-based Tenet Healthcare was among the 25 hospitals featured in the Healthier Hospitals Initiative’s 2012 Milestone Report.
Researchers at UT Southwestern Medical Center have found that alternative splicing—a process that allows a single gene to code for multiple proteins—appears to be a new potential target for anti-telomerase cancer therapy. Full Story
Researchers at UT Southwestern Medical Center have found that alternative splicing—a process that allows a single gene to code for multiple proteins—appears to be a new potential target for anti-telomerase cancer therapy. The enzyme telomerase is overexpressed in almost all cancer cells, and previous research efforts have failed to identify good telomerase inhibitors. The study by Dr. Woodring Wright and UT Southwestern colleagues in the April 4 issue of Cell Reports identifies a new approach for inhibiting telomerase, which is an enzyme that drives uncontrolled division and replication of cancer cells.
Fitch Ratings forecasts low single-digit growth for most companies in the U.S. healthcare sector in 2013, although the ratings agency’s overall outlook for the industry is stable. Its forecast covers pharmaceutical manufacturers, diagnostic and life science companies, healthcare providers, medical device makers, and healthcare services segments of the broader U.S. healthcare industry: Fitch says healthcare shows many positive growth trends—including the country’s aging population and higher rates of chronic disease, growing demand in emerging markets, and new product launches. But these are tempered by weak economic conditions and the looming fiscal cliff. Although Fitch views the Affordable Care Act as a… Full Story
4G Biometrics and Methodist Richardson Medical Center are among the winners of the Metroplex Technology Business Council’s 2012 Tech Titans awards. UTA’s Dr. Mario Romero-Ortega and UTD’s Robert L. Robb also were among those honored. OneSource Virtual was named the area’s fastest-growing tech company in North Texas, with a revenue growth of 2874% during the past three years. The winners were revealed and celebrated at a gala Friday evening held at the Hilton Anatole in Dallas. It was the 12th annual program for the MTBC, the largest technology trade association in Texas. “Tech Titans is the premier recognition of innovative… Full Story